Drugs / Haemophilus Influenzae Type b (Hib) vaccine
Haemophilus Influenzae Type b (Hib) vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00771849 Comparator | Aug 2003 → Mar 2004 | meningitis, meningococcemia | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Haemophilus Influenzae Type b (Hib) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00771849 ↗ |
| Modality | Vaccine | “Haemophilus Influenzae Type b (Hib) vaccine” NCT00771849 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00771849 ↗ |